7 results
P
adults undergoing cardiac surgery
I/C
perioperative DEX, placebo/no DEX
O
dNCR (cognitive dysfunction ≥ 1 week postoperative)
P
adult patients submitted to general anesthesia for non-cardiac surgery
I/C
dexmedetomidine (DEX), placebo
O
postoperative cognitive and behavioral dysfunction
P
1478 patients
I/C
intrathecal dexmedetomidine (DEX), placebo
O
duration of sensory block, duration of motor block, time to first analgesic request, onset of sensory block, onset of motor block, incidence of shivering, risk of transient bradycardia, risk of hypotension, incidence of postoperative nausea and vomiting
P
non-cardiac surgery
I/C
perioperative dexmedetomidine (Dex), placebo
O
post-operative acute kidney injury (AKI)
P
mouse models of IBD
I/C
Trichinella infection or derived antigens, control group
O
disease activity index (DAI), myeloperoxidase (MPO) activity, macroscopic inflammation score, microscopic inflammation score, anti-inflammatory cytokines (IL-4, TGF-β, IL-10, IL-13), proinflammatory cytokines (IFN-γ, IL-6, TNF-α, IL-17), regulatory T (Treg) cells, M1 phenotypic macrophage marker (iNOS), M2 phenotypic macrophage marker (Arg-1)
P
gynecologic and breast cancer survivors
I/C
oncology health professionals initiating and conducting open, honest discussions around sexual concerns with patients, availability of information in multiple forms, appropriate timing of information provision according to women's preferences
O
factors that prevent and/or facilitate gynecologic and breast cancer patients with sexual concerns seeking and accessing sexual health-related services
P
COVID-19 patients
I/C
3-drugs-3-formulas, conventional treatment
O
duration of fever, cough, fatigue, length of hospital stay, time for nucleic acid conversion, aggravation rate, mortality, recovery rate of chest computerized tomography manifestations, total effectiveness